Astrana Health (NASDAQ:ASTH) & Daxor (NASDAQ:DXR) Financial Analysis

Astrana Health (NASDAQ:ASTH) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, dividends and profitability.

Profitability

This table compares Astrana Health and Daxor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.04%	3.43%	1.87%
Daxor	N/A	N/A	N/A

Insider & Institutional Ownership

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 20.0% of Astrana Health shares are held by insiders. Comparatively, 59.5% of Daxor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Astrana Health and Daxor, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	2	2	6	0	2.40
Daxor	0	1	1	0	2.50

Astrana Health presently has a consensus target price of $45.29, suggesting a potential upside of 113.14%. Daxor has a consensus target price of $25.00, suggesting a potential upside of 86.29%. Given Astrana Health’s higher probable upside, analysts plainly believe Astrana Health is more favorable than Daxor.

Volatility and Risk

Astrana Health has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, Daxor has a beta of -0.09, indicating that its share price is 109% less volatile than the S&P 500.

Earnings & Valuation

This table compares Astrana Health and Daxor”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$2.90 billion	0.41	$43.15 million	$0.19	111.83
Daxor	$3.31 million	19.61	N/A	N/A	N/A

Astrana Health has higher revenue and earnings than Daxor.

Summary

Astrana Health beats Daxor on 8 of the 11 factors compared between the two stocks.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.